Find out how you can make an impact:
Contact Karen Sveda, Managing Director of Development, at email@example.com or (617) 324-7399
Make a contribution:
- Credit card (via MIT's giving website)
- Wire transfer
- Mutual fund transfers
- Donor advised funds
Gifts by check can be mailed to:
Development Assistant, Koch Institute
Massachusetts Institute of Technology
77 Massachusetts Avenue, 76-158
Cambridge, MA 02139
Koch Institute Frontier Research Fund (3890280) Give now
Supports innovative, early stage cancer research projects through the Koch Institute Frontier Research Program. These high-risk, high-reward efforts are difficult to fund with conventional funding methods but have the potential for groundbreaking translational discoveries.
Koch Institute Director's Discretionary Endowed Fund (319922) Give now
As its endowment grows over time, increasing annual income from this unrestricted fund allows the Koch Institute to plan strategically and invest where needed—people, technologies, and research—to stay at the forefront of cancer research.
Koch Institute Director's Fund (2982900) Give now
Provides unrestricted support for the Koch Institute. Your gift will be applied where it is most needed.
Angelika Amon Young Scientist Award (3646915) Give now
Pioneering geneticist, cell biologist, and long-time faculty member Angelika Amon was a mentor, advocate, and friend to many in the scientific community. Created in her memory, this fund supports awards to graduate students from institutions outside the US—including Amon’s native Austria—who embody her infectious enthusiasm for discovery science. Recipients are invited to the Koch Institute for scientific presentations and meetings with faculty and trainees.
Judith Ann Lippard Memorial Lecture (3652865) Give now
Honoring the life of Judy Lippard, the wife of Stephen J. Lippard, Arthur Amos Noyes Professor Emeritus of Chemistry at MIT, the lecture unites two extraordinary cancer centers—MIT’s Koch Institute and the Massachusetts General Hospital Cancer Center—and features individuals whose research has the possibility to change the face of women's cancers.